• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease.

作者信息

Xu Ling, Liu Jia, Lu Mengji, Yang Dongliang, Zheng Xin

机构信息

Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Liver Int. 2020 Oct;40(10):2569-2570. doi: 10.1111/liv.14564. Epub 2020 Jul 5.

DOI:10.1111/liv.14564
PMID:32558065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323225/
Abstract
摘要

相似文献

1
Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease.作者对致编辑的信的回复：2019冠状病毒病对非酒精性脂肪性肝病的潜在影响
Liver Int. 2020 Oct;40(10):2569-2570. doi: 10.1111/liv.14564. Epub 2020 Jul 5.
2
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者中COVID-19病情更严重的危险因素
Metabolism. 2020 Jul;108:154256. doi: 10.1016/j.metabol.2020.154256. Epub 2020 Apr 29.
3
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者感染 COVID-19 时病情更严重的风险因素。
Metabolism. 2020 Jul;108:154244. doi: 10.1016/j.metabol.2020.154244. Epub 2020 Apr 19.
4
Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time.非酒精性脂肪性肝病与 COVID-19：双重疫情夹击
Medicina (Kaunas). 2021 Oct 3;57(10):1057. doi: 10.3390/medicina57101057.
5
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.代谢功能障碍相关脂肪性肝病且纤维化评分升高的患者感染新型冠状病毒肺炎后出现重症的风险。
Gut. 2020 Aug;69(8):1545-1547. doi: 10.1136/gutjnl-2020-321611. Epub 2020 May 15.
6
Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.致编辑的信：肥胖、糖尿病、非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病是与新冠病毒疾病严重程度及血栓形成相关的促炎高凝状态。
Metabolism. 2021 Feb;115:154437. doi: 10.1016/j.metabol.2020.154437. Epub 2020 Nov 19.
7
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
8
Lack of genetic evidence that fatty liver disease predisposes to COVID-19.缺乏脂肪肝疾病易引发2019冠状病毒病的基因证据。
J Hepatol. 2020 Sep;73(3):709-711. doi: 10.1016/j.jhep.2020.05.015. Epub 2020 May 20.
9
Liver, NAFLD and COVID-19.肝脏、非酒精性脂肪性肝病与 COVID-19
Horm Metab Res. 2022 Aug;54(8):522-531. doi: 10.1055/a-1834-9008. Epub 2022 Apr 25.
10
Author response to Letter to the Editor 'Liver impairment associated with disease progression in COVID-19 patients'.作者对致编辑的信《COVID-19患者疾病进展相关的肝功能损害》的回复
Liver Int. 2020 Jul;40(7):1791. doi: 10.1111/liv.14497. Epub 2020 May 13.

引用本文的文献

1
Liver injury in COVID-19: A minireview.新型冠状病毒肺炎相关肝损伤：综述
World J Gastroenterol. 2022 Dec 21;28(47):6716-6731. doi: 10.3748/wjg.v28.i47.6716.
2
COVID-19, adaptative immune response and metabolic-associated liver disease.COVID-19、适应性免疫反应与代谢相关肝疾病。
Liver Int. 2021 Nov;41(11):2560-2577. doi: 10.1111/liv.15061. Epub 2021 Sep 28.

本文引用的文献

1
Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests".回复：“肝功能检查异常的新型冠状病毒肺炎患者的临床特征”
J Hepatol. 2020 Sep;73(3):713-714. doi: 10.1016/j.jhep.2020.04.042. Epub 2020 May 6.
2
Potential implications of COVID-19 in non-alcoholic fatty liver disease.2019冠状病毒病对非酒精性脂肪性肝病的潜在影响。
Liver Int. 2020 Oct;40(10):2568. doi: 10.1111/liv.14484. Epub 2020 May 25.
3
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.新型冠状病毒肺炎患者的非酒精性脂肪性肝病：一项回顾性研究。
J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8.
4
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
5
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.